- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Caraway Therapeutics Inc.
Headquarters: Cambridge, MA, United States of America
Website: N/A
Year Founded: 2018
Status: Acquired
BioCentury | Nov 21, 2023
Deals
Nov. 21 Quick Takes: Merck buying neurology play Caraway
Plus: Simcere takes Greater China rights to Connect’s IL-4R program, and updates from BeiGene, Ensem, J&J, Genmab, Alto, Ascendis and more
BioCentury | Jul 31, 2023
Distillery Therapeutics
Activating TRPML1 for uranium-induced nephrotoxicity
BioCentury | Dec 14, 2022
Emerging Company Profile
Lucy: mitochondrial solutions to CNS diseases
Company’s first indications are Parkinson’s disease, Rett syndrome
BioCentury | Sep 10, 2020
Finance
Casma to advance muscle dystrophy candidate into the clinic with $50M series B
A $50 million series B round led by The Column Group will provide Casma with enough cash to bring its lead Duchenne muscular dystrophy program into the clinic in early 2022. Launched in
BioCentury | Dec 4, 2019
Company News
Management tracks: Mittal to succeed Biocon’s Chandavarkar; plus Intercept, Nektar, Agios, Accelerate, ABPI and more
Items per page:
1 - 7 of 7